Taiwan FDA registration 69137df093e366e8f703bca0b1ff74a2
“BioTai” Bone Graft Substitute
TW: “博爾泰”人工骨粉
Taiwan·Risk Class 2·MD·MAXIGEN BIOTECH INC.·Registered Sep 04, 2017 – Nov 05, 2019CancelledRegistration details
- Analysis ID
- 69137df093e366e8f703bca0b1ff74a2
- License Form
- Ministry of Health Medical Device Manufacturing No. 005899
Company information
- Manufacturer
- MAXIGEN BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- MAXIGEN BIOTECH INC.
Product details
- Product Type (Level 1)
- N Orthopedic devices
- Product Type (Level 2)
- N3045 Resorbed calcium salt bone cavity filling device
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Sep 04, 2017
- Expiry Date
- Nov 05, 2019
- Cancellation Date
- Aug 24, 2021
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for “BioTai” Bone Graft Substitute in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 69137df093e366e8f703bca0b1ff74a2 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices